4//SEC Filing
MORRIS JESSICA EDGAR 4
Accession 0001387131-22-002106
CIK 0001430306other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:18 PM ET
Size
12.5 KB
Accession
0001387131-22-002106
Insider Transaction Report
Form 4
MORRIS JESSICA EDGAR
Chief Operating Officer
Transactions
- Award
Stock Option
2022-02-15+1,100,000→ 1,100,000 totalExercise: $0.21From: 2023-02-15Exp: 2032-02-15→ Common Stock (1,100,000 underlying) - Award
Stock Option
2022-02-15+1,100,000→ 1,100,000 totalExercise: $0.41From: 2023-02-15Exp: 2032-02-15→ Common Stock (1,100,000 underlying) - Award
Stock Option
2022-02-15+1,100,000→ 1,100,000 totalExercise: $0.62From: 2023-02-15Exp: 2032-02-15→ Common Stock (1,100,000 underlying) - Award
Stock Option
2022-02-15+1,100,000→ 1,100,000 totalExercise: $0.83From: 2023-02-15Exp: 2032-02-15→ Common Stock (1,100,000 underlying)
Footnotes (3)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001656531
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:18 PM ET
- Size
- 12.5 KB